ClinicalTrials.gg
Not yet recruitingNCT05539261Updated Sep 14, 2022

Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery

An observational study in Heart Valve Diseases and Image, sponsored by Nanjing University of Traditional Chinese Medicine. Not yet recruiting at 1 site in China. Open to participants aged 45 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-14.

Sponsored by Nanjing University of Traditional Chinese Medicine · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
45 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to clarify the changes of neurocognitive function of patients undergoing cardiac valve disease before and after surgical treatment under cardiopulmonary bypass operation, and to predict the neurological prognosis of such patients through combined imaging technology, so as to improve and avoid the occurrence of postoperative neurological dysfunction in such patients.

Read the detailed description

This study focuses on brain protection in patients with heart disease. The preoperative brain imaging and consciousness and cognition evaluation results, intraoperative brain monitoring indicators, adverse events of neurological function, brain imaging and consciousness and cognition evaluation results during the postoperative and follow-up periods were recorded. At the same time, serum markers related to perioperative neurological function were obtained to explore the relevant factors affecting neurocognitive function during the perioperative period. The research objectives to investigate the perioperative changes of neurocognitive function in patients undergoing heart valve surgery under cardiopulmonary bypass and the related factors affecting the prognosis of neurocognitive function.

02

Conditions studied

  • Heart Valve Diseases
  • Image

Browse trials for

Keywords

  • Heart Valve Diseases
  • Cardiopulmonary bypass
  • MRI Imaging
  • Neuropsychological assessment
03

In context

Heart Valve Diseases

552 studies on the registry are indexed under Heart Valve Diseases; 162 are open to participants now.

This study's planned enrollment of 30 is below the median of 300 across 226 observational studies indexed under Heart Valve Diseases.

Browse Heart Valve Diseases studies →

Lead sponsor

Nanjing University of Traditional Chinese Medicine is the lead sponsor of 17 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All of the patients of HVD group are in-patients and out-patients in the cardiac surgery department from the research center. The subjects of control group are recruited from community.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 45-80 years old.
  • Accept heart biological valve replacement or heart valvuloplasty.
  • More than 6 years of Education.
  • At baseline, the score of (MMSE) scale is more than 23 points

Exclusion criteria

Exclusion Criteria:

  • Patients who failed to obtain .
  • Preoperative diagnosis of stroke, epilepsy, history of craniocerebral surgery, cerebrovascular disease, psychosis and rescue patients with cardiopulmonary resuscitation before operation.
  • Alcoholism, illiteracy and left-handed.
  • There was severe organ hypoperfusion or organ dysfunction before operation, including: preoperative myocardial infarction \< 90 days, renal failure or dialysis, severe liver injury, digestive tract ischemia, spinal cord ischemia and iliac artery occlusion.
  • There are to magnetic resonance examination, such as claustrophobia and metal implants in the body.
  • Pregnant or lactating women.
  • Participating in other clinical studies will affect the main indicators of this study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • HVD

    Heart Valve Disease

    Device: magnetic resonance image · Diagnostic Test: Neuropsychological scale

  • HC

    Healthy controls

    Device: magnetic resonance image · Diagnostic Test: Neuropsychological scale

Interventions

  • Devicemagnetic resonance image

    Imaging data were collected in a strong magnetic field

  • Diagnostic testNeuropsychological scale

    Multi dimensional neuropsychological test

06

What researchers measure

Primary outcomes

  1. Change of brain volume before and after operation

    The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  2. Change of brain function connectivity before and after operation

    The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

Secondary outcomes

  1. Change of brain evaluate basic cognition before and after operation

    The change of basic cognition is evaluated by Mini-mental State Examination. The minimum value is 0 , and the maximum value is 30. The higher scores mean a better outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  2. Change of executive functions before and after operation evaluated by Trail-Making Test Part A

    The change of executive functions are first evaluated by Trail-Making Test Part A test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  3. Change of executive functions before and after operation evaluated by Digit Symbol Coding score

    The change of executive functions are second evaluated by Digit Symbol Coding score. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 56.53 ± 20.17. The higher scores mean a better outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  4. Change of working memory before and after operation evaluated by Forward Digit Span

    The change of working memory is first evaluated by Forward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 7.75±1.47. The higher scores mean a better outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  5. Change of working memory before and after operation evaluated by Backward Digit Span

    The change of working memory is second evaluated by Backward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 5.36±1.91. The higher scores mean a better outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  6. Change of language ability before and after operation

    The change of language ability is evaluated by Chinese Version Verbal Fluency Test. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 19.43±4.81. The higher scores mean a better outcome.

    Time frame: before operation; 7-10 Days after operation; 1 month; 6-12months

  7. Preliminary judge whether delirium occurs after operation

    Delirium is preliminary evaluate using confusion assessment method(CAM). The minimum value is 0 , and the maximum value is 4. The higher scores mean a worse outcome.

    Time frame: Witnin 96 hours after operation

  8. Fine judge whether delirium occurs after operation

    Delirium is fine evaluated using Delirium Rating Scale(DRS-R-98). The minimum value is 0 , and the maximum value is 39. The higher scores mean a worse outcome.

    Time frame: Witnin 96 hours after operation

  9. Change of plasma marker concentration before and after operation

    The change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma.

    Time frame: before operation; immediately after operation; 1,2,3,4 Days after operation

  10. Change of serum marker concentration before and after operation

    The change of serum marker concentration is evaluated by inflammatory cytokine.

    Time frame: before operation; immediately after operation; 1,2,3,4 Days after operation

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05539261
Lead sponsor
Nanjing University of Traditional Chinese Medicine
Collaborators
Xi'an Jiaotong University, Yuncheng First Hospital
Responsible party
Qianyan Liu (Principal Investgator, Nanjing University of Traditional Chinese Medicine) — Principal investigator
First posted
Sep 14, 2022
Start date
Sep 10, 2022 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Sep 14, 2022

Study contacts

Nengrui Guo
Contact
657040251@qq.com
0086-17635599999
LiJun Bai, phD
Contact
bailijun@xjtu.edu.cn
0086-15129034948
Nengrui Guo
principal investigator · Yuncheng First Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion